title: [Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease].
abstract: Single photon emission tomography is, because of its availability and the relatively low costs, the functional imaging modality currently most widely used for clinical applications in the brain. Beside the application of radiopharmaceuticals for the assessment of regional cerebral blood flow there is an increasing clinical use of more selective SPECT-radiopharmaceuticals, like amino acid analogs or receptor ligands. This article gives in his first part a critical review of the clinical applications of SPECT in neuro-oncology, epilepsy, basal ganglia disorders and cerebrovascular disease.
authors: Arbeitsgemeinschaft Neuronuklearmedizin, Deutschen Gesellschaft für Nuklearmedizin. Bartenstein@nuklear.klinik.uni-mainz.de
authors: P
authors: P
authors: Bartenstein
authors: F
authors: F
authors: Grünwald
authors: T
authors: T
authors: Kuwert
authors: K
authors: K
authors: Tatsch
authors: O
authors: O
authors: Sabri
authors: O
authors: O
authors: Benkert
authors: R
authors: R
authors: Fahlbusch
authors: G
authors: G
authors: Gründer
authors: K
authors: K
authors: Herzholz
authors: C
authors: C
authors: Weiller
mesh_terms: D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging*; D004827:Epilepsy / Q000000981:diagnostic imaging*; D006801:Humans; D009069:Movement Disorders / Q000000981:diagnostic imaging*; D009380:Neoplasms, Nerve Tissue / Q000000981:diagnostic imaging*; D009462:Neurology / Q000379:methods; D015899:Tomography, Emission-Computed, Single-Photon